Marcel Pascal Konrad

Marcel Pascal Konrad appears in our data through filings on Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) shares, published by SEDI. Over a trading history stretching from 19 July 2021 to 14 August 2023, the count stands at 6 filings.

No open-market sale appears; the market trades are 4 purchases worth €16k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 option exercise. So far in 2023, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €4,362. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The newest entry dates from 17 August 2023: an option exercise, in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). The last purchase on record was published on 26 June 2023, which is 1,219 days ago. Typically, a trade is published a median of 3 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.